Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LLIAX
|
Eric P Kang |
BUY
Open market or private purchase
|
Direct | 10,000 Added 50.0% |
$100,000
$10.0 p/Share
|
Feb 18
2025 |
|
LLIAX
|
Brooke Fapohunda
Chief Legal Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 50.0% |
$100,000
$10.0 p/Share
|
Feb 18
2025 |
|
LLIAX
|
Andrew H. O'Brien |
BUY
Open market or private purchase
|
Direct | 50,000 Added 50.0% |
$500,000
$10.0 p/Share
|
Feb 18
2025 |
|
LLIAX
|
Steven F Rocco
Director |
BUY
Open market or private purchase
|
Direct | 50,000 Added 50.0% |
$500,000
$10.0 p/Share
|
Feb 18
2025 |
|
MBX
|
Carl L Gordon
Director |
BUY
Open market or private purchase
|
Indirect | 143,170 Added 0.0% |
$1,551,962
$10.84 p/Share
|
Feb 18
2025 |
|
MBX
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Indirect | 143,170 Added 0.0% |
$1,551,962
$10.84 p/Share
|
Feb 18
2025 |
|
OESX
|
Ellen B Richstone |
BUY
Open market or private purchase
|
Direct | 13,000 Added 4.44% |
$10,920
$0.84 p/Share
|
Feb 18
2025 |
|
OESX
|
Anthony L. Otten |
BUY
Open market or private purchase
|
Direct | 5,000 Added 2.28% |
$4,150
$0.83 p/Share
|
Feb 18
2025 |
|
BRKR
|
Frank H Laukien
PRESIDENT & CEO |
BUY
Open market or private purchase
|
Direct | 20,000 Added 0.05% |
$1,019,800
$50.99 p/Share
|
Feb 18
2025 |
|
HP
|
Randy A Foutch |
BUY
Open market or private purchase
|
Direct | 3,800 Added 11.04% |
$99,750
$26.25 p/Share
|
Feb 18
2025 |
|
SLDB
|
Adage Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 252,545 Added 0.0% |
$1,909,240
$7.56 p/Share
|
Feb 18
2025 |
|
SNRG
|
Marc Hazout
Exec. Chairman, Pres. & CEO |
BUY
Open market or private purchase
|
Indirect | 6,000,000 Added 0.0% |
$120,000
$0.02 p/Share
|
Feb 18
2025 |
|
ZBIO
|
Leon O Moulder Jr
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 25,000 Added 8.59% |
$166,750
$6.67 p/Share
|
Feb 18
2025 |
|
JUVF
|
Bradley J. Wagner
Director |
BUY
Open market or private purchase
|
Direct | 112 Added 3.65% |
-
|
Feb 18
2025 |
|
JUVF
|
Joseph B. Scarnati Iii
Director |
BUY
Open market or private purchase
|
Direct | 105 Added 1.96% |
-
|
Feb 18
2025 |
|
JUVF
|
Steven C. Sliver
Director |
BUY
Open market or private purchase
|
Direct | 110 Added 7.36% |
-
|
Feb 18
2025 |
|
JUVF
|
Gary E Kelsey
Director |
BUY
Open market or private purchase
|
Direct | 107 Added 0.68% |
-
|
Feb 18
2025 |
|
JUVF
|
Christina Calkins Mazur
Director |
BUY
Open market or private purchase
|
Direct | 99 Added 1.58% |
-
|
Feb 18
2025 |
|
JUVF
|
Martin L Dreibelbis
Director |
BUY
Open market or private purchase
|
Direct | 136 Added 1.33% |
-
|
Feb 18
2025 |
|
CVS
|
Michael F Mahoney
Director |
BUY
Open market or private purchase
|
Direct | 30,000 Added 43.26% |
$2,001,000
$66.7 p/Share
|
Feb 18
2025 |
|
BLBD
|
Daniel Mark Thau
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 29.41% |
$17,425
$34.85 p/Share
|
Feb 18
2025 |
|
JUVF
|
Michael A. Buffington
Director |
BUY
Open market or private purchase
|
Direct | 106 Added 2.45% |
-
|
Feb 18
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 916 Added 0.0% |
$2,436
$2.66 p/Share
|
Feb 18
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 328 Added 0.55% |
$872
$2.66 p/Share
|
Feb 18
2025 |
|
JUVF
|
Michael W. Wolf
EVP/CFO |
BUY
Open market or private purchase
|
Direct | 2,350 Added 19.62% |
-
|
Feb 18
2025 |
|
JUVF
|
Marcie A Barber
President/CEO |
BUY
Open market or private purchase
|
Direct | 4,300 Added 8.08% |
-
|
Feb 18
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$1,402
$1402.7 p/Share
|
Feb 18
2025 |
|
ISBA
|
Jill Bourland
Director |
BUY
Open market or private purchase
|
Direct | 11 Added 0.2% |
$279
$25.44 p/Share
|
Feb 18
2025 |
|
GMGI
|
Aleksandar Milovanovic |
BUY
Open market or private purchase
|
Direct | 100,000 Added 0.13% |
$186,000
$1.86 p/Share
|
Feb 18
2025 |
|
DMAA
|
Drugs Made In America Acquisition LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 30,000 Added 0.71% |
-
|
Feb 18
2025 |
|
DMAA
|
Lynn Stockwell
CEO and Exe. Chair of Board |
BUY
Open market or private purchase
|
Indirect | 30,000 Added 0.0% |
-
|
Feb 18
2025 |
|
WYNN
|
Philip G Satre
Director |
BUY
Open market or private purchase
|
Indirect | 22,200 Added 0.0% |
$2,046,396
$92.18 p/Share
|
Feb 18
2025 |
|
NWPP
|
John D Cox
Director |
BUY
Open market or private purchase
|
Indirect | 9,000 Added 0.0% |
$27,450
$3.05 p/Share
|
Feb 18
2025 |
|
HBI
|
Robert F Moran |
BUY
Open market or private purchase
|
Direct | 74,850 Added 25.7% |
$450,596
$6.02 p/Share
|
Feb 18
2025 |
|
CPSI
|
Pinetree Capital Ltd.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,795 Added 0.0% |
$191,347
$28.16 p/Share
|
Feb 18
2025 |
|
COFS
|
Bradley F. Mc Ginnis
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.0% |
$32,840
$32.84 p/Share
|
Feb 18
2025 |
|
GABC
|
Zachary W Bawel |
BUY
Open market or private purchase
|
Direct | 175 Added 0.84% |
$7,061
$40.35 p/Share
|
Feb 15
2025 |
|
GABC
|
Susan J Ellspermann |
BUY
Open market or private purchase
|
Direct | 42 Added 0.48% |
$1,694
$40.35 p/Share
|
Feb 15
2025 |
|
GABC
|
Jack Sheidler |
BUY
Open market or private purchase
|
Direct | 44 Added 0.07% |
$1,775
$40.35 p/Share
|
Feb 15
2025 |
|
OVLY
|
Terrance P Withrow
Director |
BUY
Open market or private purchase
|
Direct | 278 Added 0.88% |
$7,800
$28.06 p/Share
|
Feb 14
2025 |
|
SNYR
|
Jack Ross
CEO and Chairman |
BUY
Open market or private purchase
|
Direct | 900 Added 0.26% |
$3,303
$3.67 p/Share
|
Feb 14
2025 |
|
ABIO
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect | 88,794 Added 0.0% |
$1,015,803
$11.44 p/Share
|
Feb 14
2025 |
|
BEAT
|
Richard Ferrari
Director |
BUY
Open market or private purchase
|
Direct | 29,412 Added 14.1% |
$50,000
$1.7 p/Share
|
Feb 14
2025 |
|
BEAT
|
Tim Cruickshank
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 17,647 Added 50.0% |
$29,999
$1.7 p/Share
|
Feb 14
2025 |
|
CBKM
|
Bradley Goris
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 4.59% |
$19,250
$19.25 p/Share
|
Feb 14
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,488 Added 0.0% |
$17,960
$12.07 p/Share
|
Feb 14
2025 |
|
BMY
|
Samit Hirawat
EVP,Chief Med.Offr.,Drug Dev. |
BUY
Open market or private purchase
|
Direct | 1,823 Added 2.77% |
$99,973
$54.84 p/Share
|
Feb 14
2025 |
|
DCOM
|
Basswood Capital Management, L.L.C. |
BUY
Open market or private purchase
|
Indirect | 186 Added 0.0% |
$5,767
$31.01 p/Share
|
Feb 14
2025 |
|
RM
|
Basswood Capital Management, L.L.C. |
BUY
Open market or private purchase
|
Indirect | 968 Added 0.0% |
$35,148
$36.31 p/Share
|
Feb 14
2025 |
|
ATAI
|
Apeiron Investment Group Ltd. |
BUY
Open market or private purchase
|
Indirect | 10,835,718 Added 0.0% |
$22,755,007
$2.1 p/Share
|
Feb 14
2025 |